Telmisartan Price by Country (2026)
$0.013 – $0.29 per unit
Official 2026 prices for telmisartan 40 mg tablet in India, Australia, the United Kingdom, the United States, South Africa and the UAE, converted to US dollars.
Telmisartan is used to treat high blood pressure and to lower cardiovascular risk.
Telmisartan 40 mg tablet: price by country
| Country | Price type | Local price per unit | Per unit (USD) | 30 units (USD) |
|---|---|---|---|---|
| India | Jan Aushadhi retail price (MRP) | ₹1.24 | $0.013 | $0.39 |
| Australia | PBS approved ex-manufacturer price | A$0.089 | $0.063 | $1.88 |
| United Kingdom | NHS Drug Tariff reimbursement price | £0.056 | $0.075 | $2.25 |
| United States | Pharmacy acquisition cost (NADAC) | $0.15 | $0.15 | $4.59 |
| South Africa | Single Exit Price (SEP) | R3.01 | $0.18 | $5.45 |
| United Arab Emirates | Abu Dhabi DoH public price | AED 1.05 | $0.29 | $8.61 |
Each country publishes a different type of price, explained on each country page. Converted at ECB reference rates of 23 October 2026.
Telmisartan prices in South Africa, the UAE, Saudi Arabia, Australia, the United Kingdom and the United States
- Telmisartan in South Africa32 products · SEPfrom R84.40
- Telmisartan in the UAE33 products · public pricefrom AED 29.50
- Telmisartan in Saudi Arabia8 products · public pricefrom SAR 36.60
- Telmisartan in Australia14 products · PBS pricefrom A$2.50
- Telmisartan in the United Kingdom3 products · Drug Tariff pricefrom £1.57
- Telmisartan in the United States3 products · NADAC pricefrom $0.11
About telmisartan
Telmisartan is a long-acting angiotensin receptor blocker taken once a day. It is especially widely used in India and other parts of Asia, both alone and in combination tablets with amlodipine or a diuretic. Like other medicines in its class, it needs periodic blood tests for kidney function and potassium.
Drug class: Angiotensin receptor blocker (ARB). Used for: high blood pressure (hypertension).
Frequently asked questions
How much does telmisartan cost?
Sources
- Pharmaceuticals & Medical Devices Bureau of India (PMBI), Department of Pharmaceuticals, Government of India. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Product & MRP List. janaushadhi.gov.in/product-portfolio/product-mrp-list. Retrieved 25 October 2026.
- Centers for Medicare & Medicaid Services (CMS). NADAC (National Average Drug Acquisition Cost) 2026 (as of 2026-10-21). data.medicaid.gov/dataset/fbb83258-11c7-47f5-8b18-5f8e79f7e704. Retrieved 25 October 2026.
- NHS Business Services Authority (NHSBSA). Drug Tariff Part VIIIA Category M prices - October 2026. www.nhsbsa.nhs.uk/sites/default/files/2026-09/Cat%20M%20Prices%20-%20Q. Retrieved 25 October 2026.
- Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS) Schedule, 1 October 2026 (PBS API). www.pbs.gov.au/. Retrieved 25 October 2026.
- National Department of Health, South Africa. Database of Medicine Prices (Single Exit Price), effective 1 October 2026. www.health.gov.za/nhi-pee/. Retrieved 25 October 2026.
- Department of Health – Abu Dhabi. Drug Master price list (public prices), version effective 2 October 2026. www.doh.gov.ae/en/resources/drug-prices. Retrieved 25 October 2026.
- European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.
Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error